Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study

Journal of Clinical Microbiology

Volumn 48, Issue 8, 2010, Pages 2665-2671

  Louvanto, Karolina ^a,b   Syrjänen, Kari J ^b   Rintala, Marjut A M ^b   Grénman, Seija E ^b   Syrjänen, Stina M ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CLEARANCE; FEMALE; GENOTYPE; GROUPS BY AGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEXUALITY; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS; AGE; CLASSIFICATION; FINLAND; FOLLOW UP; GENETICS; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PROSPECTIVE STUDY; RISK FACTOR; TIME; UTERINE CERVIX; VIROLOGY;

ADULT; AGE FACTORS; CERVIX UTERI; FEMALE; FINLAND; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

HUMAN PAPILLOMAVIRUS;

EID: 77955453869     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00783-10     Document Type: Article

References (25)

1. Anttila, M., S. Syrjänen, H. Ji, S. Saarikoski, and K. Syrjänen. 1999. Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol. 72:337-341. (Pubitemid 29118190)
2. Diggle, P. J., K.-Y. Liang, and S. L. Zeger. 1994. Analysis of longitudinal data, 1st ed. Oxford University Press, Oxford, United Kingdom.
3. Franco, E. L., L. L. Villa, J. P. Sobrinho, J. M. Prado, M. C. Rousseau, M. Désy, and T. E. Rohan. 1999. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J. Infect. Dis. 180:1415-1423.
4. Giuliano, A. R., R. Harris, R. L. Sedjo, S. Baldwin, D. Roe, M. R. Papenfuss, M. Abrahamsen, P. Inserra, S. Olvera, and K. Hatch. 2002. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study. J. Infect. Dis. 186:462-469.
5. Goodman, M. T., Y. B. Shvetsov, K. McDuffie, L. R. Wilkens, X. Zhu, P. J. Thompson, L. Ning, J. Killeen, L. Kamemoto, and B. Y. Hernandez. 2008. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res. 68:8813-8824.
6. Hardin, J., and J. M. Hilbe. 2003. Generalized estimating equations. Chapman & Hall, Boca Raton, FL.
7. Ho, G. Y., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
8. Insinga, R. P., E. J. Dasbach, E. H. Elbasha, K. L. Liaw, and E. Barr. 2007. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives. Cancer Epidemiol. Biomarkers Prev. 16:709-715.
9. Lai, C. H., A. Chao, C. J. Chang, F. Y. Chao, H. J. Huang, S. Hsueh, C. T. Lin, H. H. Cheng, C. C. Huang, J. E. Yang, T. I. Wu, H. H. Chou, and T. C. Chang. 2008. Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan. Int. J. Cancer 123:1685-1692.
10. Louvanto, K., M. Rintala, K. Syrjänen, S. Grenman, and S. Syrjänen. Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study. J. Infect. Dis., in press.
11. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
12. Muñoz, N., F. Méndez, H. Posso, M. Molano, A. J. van den Brule, M. Ronderos, C. Meijer, A. Muñoz, and the Instituto Nacional de Cancerologia HPV Study Group. 2004. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J. Infect. Dis. 190:2077-2087.
13. Plummer, M., M. Schiffman, P. E. Castle, D. Maucort-Boulch, C. M. Wheeler, and the ALTS Group. 2007. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis. 195:1582-1589.
14. Richardson, H., G. Kelsall, P. Tellier, H. Voyer, M. Abrahamowicz, A. Ferenczy, F. Coutlée, and E. L. Franco. 2003. The natural history of typespecific human papillomavirus infections in female university students. Cancer Epidemiol. Biomarkers Prev. 12:485-490.
15. Rintala, M. A., S. E. Grénman, M. E. Järvenkylä, K. J. Syrjänen, and S. M. Syrjänen. 2005. High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study. Clin. Infect. Dis. 41:1728-1733.
16. Rintala, M. A., S. E. Grénman, M. H. Puranen, E. Isolauri, U. Ekblad, P. O. Kero, and S. M. Syrjänen. 2005. Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J. Clin. Microbiol. 43:376-381.
17. Rodríguez, A. C., M. Schiffman, R. Herrero, S. Wacholder, A. Hildesheim, P. E. Castle, D. Solomon, R. Burk, and the Proyecto Epidemiológico Guanacaste Group. 2008. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J. Natl. Cancer Inst. 100:513-517.
18. Rosa, M. I., J. M. Fachel, D. D. Rosa, L. R. Medeiros, C. N. Igansi, and M. C. Bozzetti. 2008. Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am. J. Obstet. Gynecol. 199:617.e1-e7.
19. Safaeian, M., M. Kiddugavu, P. E. Gravitt, S. J. Gange, J. Ssekasanvu, D. Murokora, M. Sklar, D. Serwadda, M. J. Wawer, K. V. Shah, and R. Gray. 2008. Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiol. Biomarkers Prev. 17:1300-1307.
20. Schmitt, M., I. G. Bravo, P. J. Snijders, L. Gissmann, M. Pawlita, and T. Waterboer. 2006. Bead-based multiplex genotyping of human papillomaviruses. J. Clin. Microbiol. 44:504-512.
21. Sellors, J. W., T. L. Karwalajtys, J. Kaczorowski, J. B. Mahony, A. Lytwyn, S. Chong, J. Sparrow, and A. Lorincz. 2003. Survey of HPV in Ontario Women Group. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 168:421-425.
22. Snijders, P. J. F., A. J. C. van den Brule, H. F. J. Schrijnemakers, G. Snow, C. J. L. M. Meijer, and J. M. M. Walboomers. 1990. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J. Gen. Virol. 71:173-181.
23. Syrjänen, S., I. P. Shabalova, N. Petrovichev, V. P. Kozachenko, T. Zakharova, A. Pajanidi, J. I. Podistov, G. Chemeris, L. G. Sozaeva, E. V. Lipova, I. Tsidaeva, O. G. Ivanchenko, A. A. Pshepurko, S. Zakharenko, R. Nerovjna, L. B. Kljukina, O. A. Erokhina, M. F. Branovskaja, M. Nikitina, V. Grunberga, A. Grunberg, A. Juschenko, P. Tosi, M. Cintorino, R. Santopietro, and K. J. Syrjänen. 2005. Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study). Eur. J. Obstet. Gynecol. Reprod. Biol. 119:219-227.
24. Syrjänen, S., I. P. Shabalova, N. Petrovichev, J. Podistov, O. Ivanchenko, S. Zakharenko, R. Nerovjna, L. B. Kljukina, M. F. Branovskaja, A. Juschenko, A. P. Tosi, K. Syrjänen, and the NIS Cohort Study Group. 2005. Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union. Int. J. STD AIDS 16:217-223.
25. Trottier, H., S. Mahmud, J. C. Prado, J. S. Sobrinho, M. C. Costa, T. E. Rohan, L. L. Villa, and E. L. Franco. 2008. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J. Infect. Dis. 197:1436-1447.